Novo Nordisk shares rise after Wegovy obesity pill launch

Science

Novo Nordisk Shares Rise After Wegovy Obesity Pill Launch

By CNBC

Shares of Novo Nordisk rose more than 5% on Friday after early prescription data showed an encouraging start to the U.S. launch of the company's new GLP-1 pill for obesity. In a Friday note, TD Cowen analysts called it a "solid start" for the first-e ...Read more